Zhen Zhang
Drug developer in the pharmaceutical industry across Phase I–IV clinical and real-world studies in multiple therapeutic areas, including Oncology, Neurology/CNS, Inflammation/Immunology, Nephrology, and rare diseases. Over 17 years of experiences in clinical and real-world data analytics with over 160 peer-reviewed publications on statistical and AI/ML methods. Extensive experience in global regulatory/HTA submissions